Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Thursday - 17 September 2026

Thursday, 17 September 2026

Questions (363)

Seán Ó Fearghaíl

Question:

363. Deputy Seán Ó Fearghaíl asked the Minister for Health if she is aware of concerns raised by patients and families affected by phenylketonuria (PKU) regarding access to a medicinal product (details supplied); if the product has been assessed, or is under assessment, for reimbursement and availability in Ireland; the current status of any application for pricing and reimbursement of this treatment; and the timeline envisaged for a decision on patient access [66142/26]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Share